Gallium-68-Labeled Anti-HER2 Single-Chain Fv Fragment

Development and In Vivo Monitoring of HER2 Expression

Masashi Ueda, Hayato Hisada, Takashi Temma, Yoichi Shimizu, Hiroyuki Kimura, Masahiro Ono, Yuji Nakamoto, Kaori Togashi, Hideo Saji

Research output: Contribution to journal › Article

13 Citations (Scopus)

Abstract

Purpose: We aimed to develop a gallium-68 (Ga-68)-labeled single-chain variable fragment (scFv) targeting the human epidermal growth factor receptor 2 (HER2) to rapidly and noninvasively evaluate the status of HER2 expression.Procedures: Anti-HER2 scFv was labeled with Ga-68 by using deferoxamine (Df) as a bifunctional chelate. Biodistribution of [68Ga]Df-anti-HER2 scFv was examined with tumor-bearing mice and positron emission tomography (PET) imaging was performed. The changes in HER2 expression after anti-HER2 therapy were monitored by PET imaging.Results: [68Ga]Df-anti-HER2 scFv was obtained with high radiochemical yield after only a 5-min reaction at room temperature. The probe showed high accumulation in HER2-positive xenografts and the intratumoral distribution of radioactivity coincided with HER2-positive regions. Furthermore, [68Ga]Df-anti-HER2 scFv helped visualize HER2-positive xenografts and monitor the changes in HER2 expression after anti-HER2 therapy.Conclusion: [68Ga]Df-anti-HER2 scFv could be a promising probe to evaluate HER2 status by in vivo PET imaging, unless trastuzumab is prescribed as part of the therapy.

Original languageEnglish
Pages (from-to)102-110
Number of pages9
JournalMolecular Imaging and Biology
Volume17
Issue number1
DOIs
Publication statusPublished - 2014

Fingerprint

Immunoglobulin Variable Region
Single-Chain Antibodies
Gallium
Deferoxamine
Positron-Emission Tomography
human ERBB2 protein
Heterografts

Keywords

  • 17-DMAG
  • Gallium-68
  • Human epidermal growth factor receptor 2(HER2)
  • Positron emission tomography (PET)
  • Single-chain Fv Fragment (scFv)
  • Therapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Medicine(all)

Cite this

Gallium-68-Labeled Anti-HER2 Single-Chain Fv Fragment : Development and In Vivo Monitoring of HER2 Expression. / Ueda, Masashi; Hisada, Hayato; Temma, Takashi; Shimizu, Yoichi; Kimura, Hiroyuki; Ono, Masahiro; Nakamoto, Yuji; Togashi, Kaori; Saji, Hideo.

In: Molecular Imaging and Biology, Vol. 17, No. 1, 2014, p. 102-110.

Research output: Contribution to journal › Article

Ueda, M, Hisada, H, Temma, T, Shimizu, Y, Kimura, H, Ono, M, Nakamoto, Y, Togashi, K & Saji, H 2014, 'Gallium-68-Labeled Anti-HER2 Single-Chain Fv Fragment: Development and In Vivo Monitoring of HER2 Expression', Molecular Imaging and Biology, vol. 17, no. 1, pp. 102-110. https://doi.org/10.1007/s11307-014-0769-5
Ueda M, Hisada H, Temma T, Shimizu Y, Kimura H, Ono M et al. Gallium-68-Labeled Anti-HER2 Single-Chain Fv Fragment: Development and In Vivo Monitoring of HER2 Expression. Molecular Imaging and Biology. 2014;17(1):102-110. https://doi.org/10.1007/s11307-014-0769-5
Ueda, Masashi ; Hisada, Hayato ; Temma, Takashi ; Shimizu, Yoichi ; Kimura, Hiroyuki ; Ono, Masahiro ; Nakamoto, Yuji ; Togashi, Kaori ; Saji, Hideo. / Gallium-68-Labeled Anti-HER2 Single-Chain Fv Fragment : Development and In Vivo Monitoring of HER2 Expression. In: Molecular Imaging and Biology. 2014 ; Vol. 17, No. 1. pp. 102-110.
@article{1e1a0deeea194f8e9505db4d2bb2b874,
title = "Gallium-68-Labeled Anti-HER2 Single-Chain Fv Fragment: Development and In Vivo Monitoring of HER2 Expression",
abstract = "Purpose: We aimed to develop a gallium-68 (Ga-68)-labeled single-chain variable fragment (scFv) targeting the human epidermal growth factor receptor 2 (HER2) to rapidly and noninvasively evaluate the status of HER2 expression.Procedures: Anti-HER2 scFv was labeled with Ga-68 by using deferoxamine (Df) as a bifunctional chelate. Biodistribution of [68Ga]Df-anti-HER2 scFv was examined with tumor-bearing mice and positron emission tomography (PET) imaging was performed. The changes in HER2 expression after anti-HER2 therapy were monitored by PET imaging.Results: [68Ga]Df-anti-HER2 scFv was obtained with high radiochemical yield after only a 5-min reaction at room temperature. The probe showed high accumulation in HER2-positive xenografts and the intratumoral distribution of radioactivity coincided with HER2-positive regions. Furthermore, [68Ga]Df-anti-HER2 scFv helped visualize HER2-positive xenografts and monitor the changes in HER2 expression after anti-HER2 therapy.Conclusion: [68Ga]Df-anti-HER2 scFv could be a promising probe to evaluate HER2 status by in vivo PET imaging, unless trastuzumab is prescribed as part of the therapy.",
keywords = "17-DMAG, Gallium-68, Human epidermal growth factor receptor 2(HER2), Positron emission tomography (PET), Single-chain Fv Fragment (scFv), Therapy",
author = "Masashi Ueda and Hayato Hisada and Takashi Temma and Yoichi Shimizu and Hiroyuki Kimura and Masahiro Ono and Yuji Nakamoto and Kaori Togashi and Hideo Saji",
year = "2014",
doi = "10.1007/s11307-014-0769-5",
language = "English",
volume = "17",
pages = "102--110",
journal = "Molecular Imaging and Biology",
issn = "1536-1632",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Gallium-68-Labeled Anti-HER2 Single-Chain Fv Fragment

T2 - Development and In Vivo Monitoring of HER2 Expression

AU - Ueda, Masashi

AU - Hisada, Hayato

AU - Temma, Takashi

AU - Shimizu, Yoichi

AU - Kimura, Hiroyuki

AU - Ono, Masahiro

AU - Nakamoto, Yuji

AU - Togashi, Kaori

AU - Saji, Hideo

PY - 2014

Y1 - 2014

N2 - Purpose: We aimed to develop a gallium-68 (Ga-68)-labeled single-chain variable fragment (scFv) targeting the human epidermal growth factor receptor 2 (HER2) to rapidly and noninvasively evaluate the status of HER2 expression.Procedures: Anti-HER2 scFv was labeled with Ga-68 by using deferoxamine (Df) as a bifunctional chelate. Biodistribution of [68Ga]Df-anti-HER2 scFv was examined with tumor-bearing mice and positron emission tomography (PET) imaging was performed. The changes in HER2 expression after anti-HER2 therapy were monitored by PET imaging.Results: [68Ga]Df-anti-HER2 scFv was obtained with high radiochemical yield after only a 5-min reaction at room temperature. The probe showed high accumulation in HER2-positive xenografts and the intratumoral distribution of radioactivity coincided with HER2-positive regions. Furthermore, [68Ga]Df-anti-HER2 scFv helped visualize HER2-positive xenografts and monitor the changes in HER2 expression after anti-HER2 therapy.Conclusion: [68Ga]Df-anti-HER2 scFv could be a promising probe to evaluate HER2 status by in vivo PET imaging, unless trastuzumab is prescribed as part of the therapy.

AB - Purpose: We aimed to develop a gallium-68 (Ga-68)-labeled single-chain variable fragment (scFv) targeting the human epidermal growth factor receptor 2 (HER2) to rapidly and noninvasively evaluate the status of HER2 expression.Procedures: Anti-HER2 scFv was labeled with Ga-68 by using deferoxamine (Df) as a bifunctional chelate. Biodistribution of [68Ga]Df-anti-HER2 scFv was examined with tumor-bearing mice and positron emission tomography (PET) imaging was performed. The changes in HER2 expression after anti-HER2 therapy were monitored by PET imaging.Results: [68Ga]Df-anti-HER2 scFv was obtained with high radiochemical yield after only a 5-min reaction at room temperature. The probe showed high accumulation in HER2-positive xenografts and the intratumoral distribution of radioactivity coincided with HER2-positive regions. Furthermore, [68Ga]Df-anti-HER2 scFv helped visualize HER2-positive xenografts and monitor the changes in HER2 expression after anti-HER2 therapy.Conclusion: [68Ga]Df-anti-HER2 scFv could be a promising probe to evaluate HER2 status by in vivo PET imaging, unless trastuzumab is prescribed as part of the therapy.

KW - 17-DMAG

KW - Gallium-68

KW - Human epidermal growth factor receptor 2(HER2)

KW - Positron emission tomography (PET)

KW - Single-chain Fv Fragment (scFv)

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=84938591134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938591134&partnerID=8YFLogxK

U2 - 10.1007/s11307-014-0769-5

DO - 10.1007/s11307-014-0769-5

M3 - Article

VL - 17

SP - 102

EP - 110

JO - Molecular Imaging and Biology

JF - Molecular Imaging and Biology

SN - 1536-1632

IS - 1

ER -

Access to Document